TTK Healthcare Ltd

TTK Healthcare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

TTK Healthcare Ltd

₹ 964 0.57%
04 Feb - close price
ttkhealthcare.com BSE: 507747 NSE: TTKHLTCARE
About

TTK Healthcare Ltd is engaged in the business of Pharmaceuticals, Consumer Products, Medical Devices, Protective Devices and Foods. [1]
It is a part of TT Krishnamachari group; whose flagship company, TTK Prestige Ltd is one of the leading kitchen appliances company in India.[2]

Key Points

Business Segments
1. Consumer Products : The company markets and distributes products that transcend categories; baby care (Woodward’s Gripe Water), personal care (Eva Deodrants), home care- room & air fresheners (Good Home ), and sexual wellness (Skore). [1] The Woodward's Gripe Water is one of the oldest FMCG brands worldwide and is a market leader in the Indian colic market. It has been marketed in India since 1928. It has a distribution network of 27 warehouses, 2,600+ distributors, 650+ frontline sales teams, and a reach of ~4 lakh outlets across India. [2]

Website BSE NSE
  • Market Cap ₹ 1,362 Cr.
  • Current Price ₹ 964
  • High / Low ₹ 1,402 / 949
  • Stock P/E 19.6
  • Book Value ₹ 768
  • Dividend Yield 1.04 %
  • ROCE 9.26 %
  • ROE 6.89 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 42.0% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 29.2%

Cons

  • The company has delivered a poor sales growth of 4.42% over past five years.
  • Earnings include an other income of Rs.59.6 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Diversified Diversified Diversified Diversified

Part of BSE Allcap BSE Industrials

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
183 180 202 186 184 181 208 198 205 190 226 204 209
174 165 192 176 179 169 201 190 197 178 224 198 202
Operating Profit 8 15 10 10 5 12 7 8 8 12 3 5 7
OPM % 5% 8% 5% 5% 3% 7% 3% 4% 4% 6% 1% 3% 3%
12 12 15 16 16 16 37 18 18 13 18 19 10
Interest 1 1 1 1 0 1 1 1 1 1 1 1 1
Depreciation 3 3 3 3 3 3 2 2 2 2 2 2 2
Profit before tax 16 23 21 22 18 24 41 23 23 22 18 21 14
Tax % 26% 27% 24% 26% 27% 25% 23% 26% 26% 26% 26% 4% 25%
12 17 16 16 13 18 32 17 17 16 13 20 11
EPS in Rs 8.49 11.99 11.09 11.33 9.12 12.93 22.35 12.17 11.84 11.43 9.20 14.43 7.45
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
416 483 519 528 578 628 646 476 599 725 753 801 830
396 453 478 489 535 578 617 457 577 694 715 767 803
Operating Profit 20 30 40 38 43 50 28 19 22 31 37 35 27
OPM % 5% 6% 8% 7% 7% 8% 4% 4% 4% 4% 5% 4% 3%
6 7 6 6 8 8 9 28 42 643 63 85 60
Interest 3 4 3 3 5 3 3 2 3 5 3 3 3
Depreciation 3 6 7 12 15 15 14 13 13 13 13 8 9
Profit before tax 20 26 36 29 30 39 19 32 48 657 84 108 75
Tax % 37% 39% 36% 36% 40% 38% 37% -44% 13% 3% 25% 25%
12 16 23 19 18 24 12 46 42 640 63 82 60
EPS in Rs 15.95 20.81 29.19 24.13 12.86 17.25 8.72 32.87 29.43 452.72 44.47 57.79 42.51
Dividend Payout % 25% 22% 17% 21% 39% 29% 34% 18% 34% 2% 22% 17%
Compounded Sales Growth
10 Years: 5%
5 Years: 4%
3 Years: 10%
TTM: 5%
Compounded Profit Growth
10 Years: 16%
5 Years: 42%
3 Years: 22%
TTM: 2%
Stock Price CAGR
10 Years: 1%
5 Years: 10%
3 Years: 1%
1 Year: -24%
Return on Equity
10 Years: 23%
5 Years: 26%
3 Years: 29%
Last Year: 7%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 8 8 8 8 14 14 14 14 14 14 14 14 14
Reserves 99 110 128 150 219 237 235 281 316 939 987 1,051 1,071
32 42 38 23 47 29 30 19 22 27 23 24 27
102 115 128 104 127 136 152 180 207 189 183 192 184
Total Liabilities 240 275 303 285 407 416 431 494 559 1,170 1,206 1,281 1,296
54 52 106 99 110 98 89 85 80 71 75 81 78
CWIP 2 46 1 0 1 2 9 0 0 3 1 0 0
Investments 0 0 10 9 9 13 9 13 15 13 13 11 12
184 177 185 177 288 304 325 395 463 1,083 1,118 1,189 1,205
Total Assets 240 275 303 285 407 416 431 494 559 1,170 1,206 1,281 1,296

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
13 39 37 18 25 17 20 96 45 -25 -5 -4
-15 -49 -27 5 -22 10 -13 -77 -30 32 28 20
2 3 -11 -23 -7 -31 -10 -17 -10 -12 -22 -18
Net Cash Flow 0 -7 -0 0 -4 -4 -4 2 5 -6 2 -2

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 34 34 33 24 35 47 43 46 33 46 42 41
Inventory Days 64 62 66 65 80 77 101 123 102 89 105 107
Days Payable 56 50 53 100 130 101 121 170 134 116 110 106
Cash Conversion Cycle 41 46 46 -11 -16 22 23 -2 1 19 36 43
Working Capital Days -24 -31 -38 -24 -30 -6 -3 -32 -28 4 49 48
ROCE % 17% 20% 23% 18% 15% 15% 8% 6% 8% 10% 9% 9%

Shareholding Pattern

Numbers in percentages

6 Recently
Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
74.57% 74.57% 74.57% 74.57% 74.57% 74.57% 74.57% 74.57% 74.57% 74.57% 74.57% 74.57%
2.38% 2.40% 1.85% 1.85% 1.85% 1.87% 1.90% 1.90% 1.90% 1.89% 1.90% 1.89%
2.99% 3.27% 3.23% 3.13% 1.14% 1.14% 1.14% 1.14% 1.14% 1.18% 1.18% 1.08%
20.07% 19.76% 20.37% 20.46% 22.45% 22.44% 22.39% 22.39% 22.40% 22.37% 22.37% 22.46%
No. of Shareholders 15,81816,10915,67216,65117,22116,93015,76215,78015,89916,11216,13422,481

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls

  • Sep 2016
    Transcript
    AI Summary
    PPT